These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37648962)

  • 1. Association of TP53 rs1042522 G > C, MDM2 rs2279744 T > G, and miR-34b/c rs4938723 T > C polymorphisms with aneuploidy pregnancy susceptibility.
    Chan Y; Xu W; Feng Y; Zhang Y; Li S; Geng Z; Liu Z; Zhao Q; Zhang J; Zhu B
    BMC Pregnancy Childbirth; 2023 Aug; 23(1):624. PubMed ID: 37648962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
    Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
    J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
    Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
    Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients.
    Wang X; Wang YZ; Ma KW; Chen X; Li W
    Oncol Res Treat; 2014; 37(4):176-80. PubMed ID: 24732641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis.
    Bulgakova O; Kussainova A; Bersimbaev R
    Vavilovskii Zhurnal Genet Selektsii; 2020 Nov; 24(7):777-784. PubMed ID: 33959694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
    Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
    Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
    Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
    Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children.
    Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers.
    Li L; Zhu J; Lu T; Liu W; Tang J; Zhang J; Wang Y; Li Y; Li S; Zhou H; Xia H; He J; Cheng J
    Transl Oncol; 2019 Oct; 12(10):1282-1288. PubMed ID: 31325764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
    Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
    Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between TP53 and MDM2 Polymorphisms and the Follicle-Stimulating Hormone/Luteinizing Hormone Ratio in Infertile Women.
    Chan Y; Zhu B; Zhang J; Luo Y; Tang W
    Genet Test Mol Biomarkers; 2018 Jul; 22(7):405-412. PubMed ID: 29957069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
    Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
    Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review.
    Yu M; Zhang Q; Zhao X
    Front Oncol; 2022; 12():973077. PubMed ID: 36059664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.
    Zając A; Smolarz B; Stachowiak G; Wilczyński JR
    Med Oncol; 2014 Nov; 31(11):286. PubMed ID: 25316267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study.
    Tripon F; Iancu M; Trifa A; Crauciuc GA; Boglis A; Balla B; Cosma A; Dima D; Candea M; Lazar E; Jimbu L; Banescu C
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.